The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...

Therefore, an ischemic stroke is caused by an interruption of blood flow to the brain from ... the point of the blockage with ...

Ischemic stroke (IS) and cardiovascular disease (CVD ... For this reason pharmacogenetics and pharmacogenomics opened a new era in the treatment of IS. Unfortunately, genetics studies to date ...

Background: Fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) might be useful for predicting and functional outcome in ischemic stroke patients after endovascular thrombectomy ...

The study demonstrated that mechanical thrombectomy is a safe and effective method for stroke patients in India, achieving ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...

India's first dedicated stroke registry, PRAAN, showcases mechanical thrombectomy's efficacy for acute ischemic stroke. Medtronic's study, involving 200 patients across 14 centers, shows high success ...

The same doctors who used that drug for the first time in the world are now testing another drug to help people who suffer a ...

The other most common type of stroke is the Ischemic stroke that occurs when there is a blood clot or something that blocks ...

Contemporary thrombolytics in acute ischemic stroke are limited to administration within 4.5 hours of last known normal. JX10 (formerly TMS-007), a Stachybotrys microspora triprenyl phenol family ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company’s ...